InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Bryce Joanne. Director active across 1 company, notably Disc Medicine, Inc.. In total, 8 disclosures have been published. History available since 28 June 2023. The latest transaction was filed on 10 January 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Bryce Joanne is a declarant linked to Disc Medicine, Inc. (XNAS), where he is Chief Financial Officer. The record shows 8 filings in total, and the 8 sampled filings cover the period from 2023-06-30 to 2024-03-01, with the transaction nature listed as Levée d'options and buy and sell amounts of EUR 0.